Pfizer CEO Albert Bourla joins The Exchange to discuss new developments with his company’s Covid vaccine, one of the two mRNA vaccines approved for emergency use in the U.S. The company is reporting new data about waning immunity and protection…
Dr Howard Weiner from the Harvard Medical School and Tiziana Life Sciences PLC’s (LON:TILS) (NASDAQ:TLSA) scientific advisory board chairman speaks to Proactive’s Andrew Scott following the news they’ve completed the clinical trial of its nasally administered Foralumab for the treatment…
Moderna’s stock fell 8% on Thursday after a report said the biotech company’s late-stage trial for a potential coronavirus vaccine will be delayed. CNBC’s Meg Tirrell reports. For more coronavirus live updates: Moderna’s stock fell by as much as 9.4%…